Search

Travis Sloan Chambers

Examiner (ID: 5702, Phone: (571)272-6813 , Office: P/2831 )

Most Active Art Unit
2831
Art Unit(s)
2839, 2831, 2833
Total Applications
1595
Issued Applications
1356
Pending Applications
75
Abandoned Applications
200

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7097810 [patent_doc_number] => 20050130269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Fusion proteins' [patent_app_type] => utility [patent_app_number] => 10/501071 [patent_app_country] => US [patent_app_date] => 2003-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8614 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130269.pdf [firstpage_image] =>[orig_patent_app_number] => 10501071 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/501071
Fusion proteins Jan 9, 2003 Issued
Array ( [id] => 902728 [patent_doc_number] => 07335490 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-26 [patent_title] => 'Use of erythropoietin for the preventive or curative treatment of cardiac failure' [patent_app_type] => utility [patent_app_number] => 10/500913 [patent_app_country] => US [patent_app_date] => 2003-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6409 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/335/07335490.pdf [firstpage_image] =>[orig_patent_app_number] => 10500913 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/500913
Use of erythropoietin for the preventive or curative treatment of cardiac failure Jan 8, 2003 Issued
Array ( [id] => 935510 [patent_doc_number] => 06974860 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-12-13 [patent_title] => 'Target recognizing binding agents' [patent_app_type] => utility [patent_app_number] => 10/335181 [patent_app_country] => US [patent_app_date] => 2002-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 28 [patent_no_of_words] => 27886 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/974/06974860.pdf [firstpage_image] =>[orig_patent_app_number] => 10335181 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/335181
Target recognizing binding agents Dec 29, 2002 Issued
Array ( [id] => 5710947 [patent_doc_number] => 20060052292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Adiponectin fragments and conjugates' [patent_app_type] => utility [patent_app_number] => 10/498665 [patent_app_country] => US [patent_app_date] => 2002-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 73595 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20060052292.pdf [firstpage_image] =>[orig_patent_app_number] => 10498665 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/498665
Adiponectin fragments and conjugates Dec 19, 2002 Abandoned
Array ( [id] => 6797454 [patent_doc_number] => 20030176328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Adiponectin fragments and conjugates' [patent_app_type] => new [patent_app_number] => 10/325717 [patent_app_country] => US [patent_app_date] => 2002-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 74109 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176328.pdf [firstpage_image] =>[orig_patent_app_number] => 10325717 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/325717
Adiponectin fragments and conjugates Dec 19, 2002 Abandoned
Array ( [id] => 7105791 [patent_doc_number] => 20050107598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'C-type lectin polypeptide, polynucleotide and methods of making and use thereof' [patent_app_type] => utility [patent_app_number] => 10/499184 [patent_app_country] => US [patent_app_date] => 2002-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 32649 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20050107598.pdf [firstpage_image] =>[orig_patent_app_number] => 10499184 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/499184
C-type lectin polypeptides Dec 18, 2002 Issued
Array ( [id] => 7022274 [patent_doc_number] => 20050016676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-27 [patent_title] => 'Method and kit providing bioadhesive binding or coating with polyphenolic mussel proteins' [patent_app_type] => utility [patent_app_number] => 10/498793 [patent_app_country] => US [patent_app_date] => 2002-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4148 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20050016676.pdf [firstpage_image] =>[orig_patent_app_number] => 10498793 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/498793
Method and kit providing bioadhesive binding or coating with polyphenolic mussel proteins Dec 12, 2002 Issued
Array ( [id] => 7413125 [patent_doc_number] => 20040106779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Modified factor IX preparation' [patent_app_type] => new [patent_app_number] => 10/309877 [patent_app_country] => US [patent_app_date] => 2002-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4207 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20040106779.pdf [firstpage_image] =>[orig_patent_app_number] => 10309877 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/309877
Modified factor IX preparation Dec 2, 2002 Abandoned
Array ( [id] => 6634302 [patent_doc_number] => 20030211538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'CAP-Gly domain structure and uses thereof' [patent_app_type] => new [patent_app_number] => 10/309763 [patent_app_country] => US [patent_app_date] => 2002-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 29977 [patent_no_of_claims] => 98 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211538.pdf [firstpage_image] =>[orig_patent_app_number] => 10309763 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/309763
CAP-Gly domain structure and uses thereof Dec 2, 2002 Abandoned
Array ( [id] => 6792482 [patent_doc_number] => 20030087826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Conjugates comprising two active agents' [patent_app_type] => new [patent_app_number] => 10/302428 [patent_app_country] => US [patent_app_date] => 2002-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4469 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20030087826.pdf [firstpage_image] =>[orig_patent_app_number] => 10302428 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/302428
Conjugates comprising two active agents Nov 21, 2002 Issued
Array ( [id] => 7429567 [patent_doc_number] => 20040001832 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Alstroem syndrome gene, gene variants, expressed protein and methods of diagnosis for Alstroem syndrome' [patent_app_type] => new [patent_app_number] => 10/292576 [patent_app_country] => US [patent_app_date] => 2002-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 4508 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0001/20040001832.pdf [firstpage_image] =>[orig_patent_app_number] => 10292576 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/292576
Alstroem syndrome gene, gene variants, expressed protein and methods of diagnosis for Alstroem syndrome Nov 11, 2002 Abandoned
Array ( [id] => 6855578 [patent_doc_number] => 20030129079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Method for protein-preserving purification of contaminated biological liquids' [patent_app_type] => new [patent_app_number] => 10/278814 [patent_app_country] => US [patent_app_date] => 2002-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1158 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20030129079.pdf [firstpage_image] =>[orig_patent_app_number] => 10278814 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/278814
Method for protein-preserving purification of contaminated biological liquids Oct 23, 2002 Abandoned
Array ( [id] => 6765597 [patent_doc_number] => 20030099996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'VELP2, a vascular endothelial cell specific and LIM domain containing molecule and uses therefor' [patent_app_type] => new [patent_app_number] => 10/273680 [patent_app_country] => US [patent_app_date] => 2002-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40244 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20030099996.pdf [firstpage_image] =>[orig_patent_app_number] => 10273680 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/273680
VELP2, a vascular endothelial cell specific and LIM domain containing molecule and uses therefor Oct 17, 2002 Abandoned
Array ( [id] => 793030 [patent_doc_number] => 06982075 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-01-03 [patent_title] => 'Use of pulmonary surfactant' [patent_app_type] => utility [patent_app_number] => 10/491961 [patent_app_country] => US [patent_app_date] => 2002-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3407 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/982/06982075.pdf [firstpage_image] =>[orig_patent_app_number] => 10491961 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/491961
Use of pulmonary surfactant Oct 9, 2002 Issued
Array ( [id] => 707374 [patent_doc_number] => 07060460 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-13 [patent_title] => 'Method for reconstituting a recombinant protein to its biologically active form' [patent_app_type] => utility [patent_app_number] => 10/261508 [patent_app_country] => US [patent_app_date] => 2002-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8433 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/060/07060460.pdf [firstpage_image] =>[orig_patent_app_number] => 10261508 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/261508
Method for reconstituting a recombinant protein to its biologically active form Oct 1, 2002 Issued
Array ( [id] => 7211746 [patent_doc_number] => 20050054037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Ferroportin-1 mutant' [patent_app_type] => utility [patent_app_number] => 10/490795 [patent_app_country] => US [patent_app_date] => 2002-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10001 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054037.pdf [firstpage_image] =>[orig_patent_app_number] => 10490795 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/490795
Ferroportin-1 mutant Sep 30, 2002 Abandoned
Array ( [id] => 6684178 [patent_doc_number] => 20030120042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Process for producing recombinant protein' [patent_app_type] => new [patent_app_number] => 10/240295 [patent_app_country] => US [patent_app_date] => 2002-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10292 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20030120042.pdf [firstpage_image] =>[orig_patent_app_number] => 10240295 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/240295
Process for producing recombinant protein Sep 26, 2002 Abandoned
Array ( [id] => 7226615 [patent_doc_number] => 20040072990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Antimicrobial peptides with reduced hemolysis and methods of their use' [patent_app_type] => new [patent_app_number] => 10/247476 [patent_app_country] => US [patent_app_date] => 2002-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 3510 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072990.pdf [firstpage_image] =>[orig_patent_app_number] => 10247476 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/247476
Antimicrobial peptides with reduced hemolysis and methods of their use Sep 19, 2002 Abandoned
Array ( [id] => 6851379 [patent_doc_number] => 20030143582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Human CDC4 modulates cyclin E degradation' [patent_app_type] => new [patent_app_number] => 10/245618 [patent_app_country] => US [patent_app_date] => 2002-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 23407 [patent_no_of_claims] => 155 [patent_no_of_ind_claims] => 37 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143582.pdf [firstpage_image] =>[orig_patent_app_number] => 10245618 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/245618
Human CDC4 modulates cyclin E degradation Sep 15, 2002 Abandoned
Array ( [id] => 985396 [patent_doc_number] => 06924124 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-08-02 [patent_title] => 'Feeding strategies for cell culture' [patent_app_type] => utility [patent_app_number] => 10/227154 [patent_app_country] => US [patent_app_date] => 2002-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5880 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/924/06924124.pdf [firstpage_image] =>[orig_patent_app_number] => 10227154 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/227154
Feeding strategies for cell culture Aug 22, 2002 Issued
Menu